Answers are grounded in this paper and cite their sources.
ADVERTISEMENT RETURN TO ISSUELetterNEXT(S)-(−)-4-[4-[2-(Isochroman-1-yl)ethyl]piperazin-1-yl]benzenesulfonamide, a Selective Dopamine D4 AntagonistRuth E. TenBrink, Carol L. Bergh, J. Neil Duncan, Douglas W. Harris, R. M. Huff, Robert A. Lahti, Charles F. Lawson, Barry S. Lutzke, Iain J. Martin, Susan A. Rees, Siusaidh K. Schlachter, John C. Sih, and Martin W. SmithView Author Information Pharmacia & Upjohn, Inc., Kalamazoo, Michigan 49001 Cite this: J. Med. Chem. 1996, 39, 13, 2435–2437Publication Date (Web):June 21, 1996Publication History Received26 January 1996Published online21 June 1996Published inissue 1 January 1996https://pubs.acs.org/doi/10.1021/jm960084fhttps://doi.org/10.1021/jm960084frapid-communicationACS PublicationsCopyright © 1996 American Chemical SocietyRequest reuse permissionsArticle Views1251Altmetric-Citations86LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstract
No takes yet. Share an insight, caveat, or question.
TenBrink et al. (1996) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: